The U.S. Federal Trade Commission is looking into how big pharmacy benefit managers like CVS Caremark affect pricing and patients’ access to prescription drugs at a time when costs of some medicines, even older ones like insulin, have skyrocketed, the agency said Tuesday.
As part of the probe, the FTC is sending demands for information to CVS Health Corp’s Caremark, Humana Inc, Cigna Corp’s Express Scripts, and UnitedHealth Group’s OptumRx, among others.
Pharmacy benefit managers (PBMs) negotiate with drugmakers for rebates and lower fees on behalf of employers and other clients, and reimburse pharmacies for prescriptions they dispense…. » Read full article
Bombshell Study – Popular Cooking Staple Linked to Memory Loss?
Aluminum Foil Is a Major Source of Aluminum Exposure, Studies Show Analysis by Dr. Joseph Mercola – November 06, 2024 Admin Note: foil is a staple for many and
